Tetrous, Inc., a Sherman Oaks start up focused on bone-to-tendon healing following orthopedic surgery, is pleased to announce the successful closure of its Series A financing round, raising a total of ...

However, IL-23 blockers are ineffective in axial inflammation in man. This study investigated γδT-cell subsets in the normal human enthesis to explore the biology of the IL-23/17 axis. Methods Human ...